Biomarker Testing in Advanced Cancer Still Lags Behind Guideline Recommendations
(MedPage Today) -- Only a third of patients with advanced cancer had molecular testing to help guide the use of targeted therapies, a review of 26,000 patients showed.
Overall, 35% of patients' records had evidence of comprehensive genomic profiling...
Overall, 35% of patients' records had evidence of comprehensive genomic profiling...